Additional prognostic impact of the percentage of erythroid cells in the bone marrow of patients with myelodysplastic syndromes.

[1]  P. Nguyen,et al.  Myelodysplastic syndromes , 2009, Nature Reviews Disease Primers.

[2]  P. Ji,et al.  Age-related inflammatory bone marrow microenvironment induces ineffective erythropoiesis mimicking del(5q) MDS , 2017, Leukemia.

[3]  A nationwide survey of hypoplastic myelodysplastic syndrome (a multicenter retrospective study) , 2017, American journal of hematology.

[4]  M. Fontenay,et al.  Dyserythropoiesis of myelodysplastic syndromes , 2017, Current opinion in hematology.

[5]  S. Méndez-Ferrer,et al.  Myeloid malignancies and the microenvironment. , 2017, Blood.

[6]  L. Arenillas,et al.  Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic Syndromes. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  J. Bennett,et al.  Dysplastic erythroid precursors in the myelodysplastic syndromes and the acute myeloid leukemias: Is there biologic significance? (How should blasts be counted?). , 2016, Leukemia research.

[8]  U. Germing,et al.  Cellularity, characteristics of hematopoietic parameters and prognosis in myelodysplastic syndromes , 2015, European journal of haematology.

[9]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[10]  U. Germing,et al.  Validation and proposals for a refinement of the WHO 2008 classification of myelodysplastic syndromes without excess of blasts. , 2013, Leukemia research.

[11]  Luca Malcovati,et al.  Revised international prognostic scoring system for myelodysplastic syndromes. , 2012, Blood.

[12]  U. Germing,et al.  Evaluation of dysplasia through detailed cytomorphology in 3156 patients from the Düsseldorf Registry on myelodysplastic syndromes. , 2012, Leukemia research.

[13]  M. Yao,et al.  Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies , 2008, Leukemia.

[14]  T Hamblin,et al.  International scoring system for evaluating prognosis in myelodysplastic syndromes. , 1997, Blood.

[15]  G Flandrin,et al.  Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. , 1985, Annals of internal medicine.